Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Lublin
Clinical trial register · Poland

Clinical Trials in Lublin, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2721 matching records held by the registry are in this view. Synced 19 Nov 2026, 03:18 UTC
2721
Studies in scope
all four open statuses
1385
Recruiting now
open to new participants
507
Lead sponsors
across recruiting studies
Top sites
Warsaw 31 Krakow 30 Wroclaw 29 Katowice 24 Poznan 21

Trials with a site in Lublin

15 of 2721 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Pfizer
Phase 3
954
Bialystok, Gdansk, Lublin, Poznan, Wroclaw
2026-06-10
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
Pfizer
Phase 3
1,410
Radom, Katowice, Kielce, Lodz, Lublin, Opole, Wroclaw, Tomaszów Mazowiecki
2026-01-06
Recruiting
Pfizer
Phase 3
450
Krakow, Lublin, Warsaw, Chorzów, Lodz, Ostrowiec Świętokrzyski
2025-12-02
Recruiting
Pfizer
Phase 2
200
Warsaw, Chorzów, Gdansk, Lublin, Tarnów, Wroclaw
2025-10-30
Recruiting
Pfizer
Phase 3
680
Lublin, Poznan, Tomaszów Mazowiecki, Lodz
2025-09-29
Recruiting
Pfizer
Phase 3
1,000
Poznan, Wroclaw, Szczecin, Koszalin, Krakow, Lublin, Rzeszów
2025-09-28
Recruiting
Pfizer
Phase 3
140
Krakow, Wroclaw, Lublin, Warsaw, Bialystok, Katowice, Rzeszów, Lodz
2025-09-10
Active, closed
Pfizer
Phase 3
208
Krakow, Wroclaw, Lublin, Warsaw, Bialystok, Katowice, Ossy, Rzeszów
2025-07-31
Active, closed
Pfizer
Phase 3
151
Krakow, Lublin, Warsaw, Chorzów, Katowice, Lodz, Ostrowiec Świętokrzyski
2025-07-24
Recruiting
Pfizer
Phase 3
714
Poznan, Lublin, Warsaw, Gdansk, Gliwice, Lodz
2025-07-23
Recruiting
Pfizer
Phase 3
674
Poznan, Krakow, Wroclaw, Lublin, Nowa Sól, Warsaw, Katowice, Sosnowiec
2025-04-01
Recruiting
Pfizer
Phase 3
723
Krakow, Oświęcim, Wroclaw, Lublin, Warsaw, Katowice
2025-03-11
Active, closed
Pfizer
Phase 3
636
Bydgoszcz, Krakow, Wroclaw, Lublin, Warsaw
2024-11-15
Active, closed
Pfizer
Phase 3
900
Krakow, Wroclaw, Lublin, Warsaw, Koszalin, Opole, Piotrkow Trybunalski
2024-10-22
Recruiting
Pfizer
Phase 3
640
Poznan, Krakow, Wroclaw, Lublin, Warsaw, Katowice
2022-02-28
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 November 2026. https://priyalifescience.com/clinical-trials-poland/city/lublin

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,721 studies in total at the last sync on 19 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Lublin that also match the filters currently applied.

How many clinical trials are recruiting in Lublin?

11 of the 15 studies on this page are recruiting new participants as of the 19 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lublin), 15 studies
PhaseStudiesRecruitingShare
Phase 3141093.3%
Phase 2116.7%

Most active sponsors

Lead sponsors with the most studies (Lublin)
Lead sponsorStudiesRecruiting
Pfizer1511
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.